Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jyri J. Taskila"'
Autor:
Tomi Bergström, Jaakko Seikkula, Birgitta Alakare, Mia Kurtti, Päivi Köngäs‐Saviaro, Elina Löhönen, Jouko Miettunen, Hannele Mäkiollitervo, Jyri J. Taskila, Katriina Virta, Kari Valtanen
Publikováno v:
Early Intervention in Psychiatry
Aim: To evaluate the 10-year treatment outcomes and cost-effectiveness of adolescents' mental health treatment initiated under the social network-oriented open dialogue (OD) approach. -- Methods: This longitudinal register-based study included all pe
Background The open dialogue (OD) approach includes the need-adapted use of psychiatric medication in treating first-episode psychosis (FEP), but there is limited information on how psychiatric medications are actually used in OD-based services. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d755c40b576b7940932c0a959d31a32
http://urn.fi/URN:NBN:fi:jyu-202211155205
http://urn.fi/URN:NBN:fi:jyu-202211155205
Autor:
Birgitta Alakare, Juha Holma, Päivi Köngäs-Saviaro, Jyri J. Taskila, Jaakko Seikkula, Tomi Bergström
Publikováno v:
Community mental health journal. 58(5)
Open Dialogue (OD) is an integrated approach to mental health care, which has demonstrated promising outcomes in the treatment of first-episode psychosis (FEP) in Finnish Western Lapland region. However, little is known how treatment under OD is retr
Autor:
Jukka Aaltonen, Tomi Bergström, Jyri J. Taskila, Pirjo Mäki, Birgitta Alakare, Asko Tolvanen, Päivi Köngäs-Saviaro, Jaakko Seikkula
Publikováno v:
Psychiatry Research. 270:168-175
Open Dialogue (OD) is a family-oriented early intervention approach which has demonstrated good outcomes in the treatment of first-episode psychosis (FEP). Nevertheless, more evidence is needed. In this register-based cohort study the long-term outco
Autor:
Lindh E; Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland., Smura T; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, HUSLAB, Clinical Microbiology, Helsinki University Hospital, Finland., Blomqvist S; Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland., Liitsola K; Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland., Vauhkonen H; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Savolainen L; Northern Finland Laboratory Center Nordlab, Oulu, Finland., Ikonen J; Northern Finland Laboratory Center, Nordlab, Länsi-Pohja, Finland., Ronkainen J; Primary Health Care Center City of Tornio, Finland and Center for Life Course Health Research, University of Oulu, Finland., Taskila J; Länsi-Pohja Health Care District, Kemi, Finland., Taskila T; Primary Health Care Center City of Kemi, Kemi, Finland., Sakaranaho P; Municipality of Keminmaa, Keminmaa, Finland., Savolainen-Kopra C; Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland., Vapalahti O; Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, HUSLAB, Clinical Microbiology, Helsinki University Hospital, Finland., Ikonen N; Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2022 Apr; Vol. 27 (16).